Kevin C. Barry

3.3k total citations · 2 hit papers
18 papers, 1.5k citations indexed

About

Kevin C. Barry is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Kevin C. Barry has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Kevin C. Barry's work include Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Kevin C. Barry is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Kevin C. Barry collaborates with scholars based in United States, Israel and Australia. Kevin C. Barry's co-authors include Matthew F. Krummel, Mark J. Smyth, Tobias Bald, Russell E. Vance, Mary F. Fontana, Zhao‐Qing Luo, Marko Spasić, Edward W. Roberts, Xihui Shen and Adil Daud and has published in prestigious journals such as Cell, Journal of Clinical Investigation and The EMBO Journal.

In The Last Decade

Kevin C. Barry

18 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity

2019 443 citations Mikhail Binnewies, Adriana M. Mujal et al. Cell profile →
The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

2020 364 citations Tobias Bald, Matthew F. Krummel et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin C. Barry United States	15	911	582	581	231	160	18	1.5k
Norbert Hilf Germany	16	1.3k 1.4×	467 0.8×	1.0k 1.8×	54 0.2×	218 1.4×	31	1.9k
Roberto Carrió United States	18	1.1k 1.2×	340 0.6×	819 1.4×	45 0.2×	199 1.2×	27	1.8k
Ruzeen Patwa Australia	9	343 0.4×	238 0.4×	670 1.2×	74 0.3×	118 0.7×	13	1.5k
Andrea Itano United States	21	2.4k 2.6×	420 0.7×	640 1.1×	37 0.2×	171 1.1×	33	3.1k
Rachid Marhaba Germany	20	355 0.4×	358 0.6×	678 1.2×	100 0.4×	59 0.4×	24	1.4k
Purnima Dubey United States	20	583 0.6×	487 0.8×	556 1.0×	29 0.1×	147 0.9×	45	1.5k
Machie Sakuma Japan	13	1.1k 1.2×	208 0.4×	528 0.9×	45 0.2×	277 1.7×	16	1.6k
Joanne E. Davis Australia	17	527 0.6×	307 0.5×	408 0.7×	87 0.4×	225 1.4×	36	1.2k
Fazel Shokri Iran	21	611 0.7×	218 0.4×	406 0.7×	53 0.2×	145 0.9×	74	1.2k
Béatrice Bréart France	17	1.3k 1.4×	458 0.8×	604 1.0×	24 0.1×	157 1.0×	19	2.0k

Countries citing papers authored by Kevin C. Barry

Since Specialization

Citations

This map shows the geographic impact of Kevin C. Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin C. Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin C. Barry more than expected).

Fields of papers citing papers by Kevin C. Barry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin C. Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin C. Barry. The network helps show where Kevin C. Barry may publish in the future.

Co-authorship network of co-authors of Kevin C. Barry

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin C. Barry. A scholar is included among the top collaborators of Kevin C. Barry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin C. Barry. Kevin C. Barry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Daniel, Sara K., Kevin M. Sullivan, Renske J.E. van den Bijgaart, et al.. (2024). Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade. Scientific Reports. 14(1). 5109–5109. 5 indexed citations

Dinh, Timothy A., Alan F. Utria, Kevin C. Barry, et al.. (2022). A framework for fibrolamellar carcinoma research and clinical trials. Nature Reviews Gastroenterology & Hepatology. 19(5). 328–342. 22 indexed citations

Bickett, Thomas E., Michael W. Knitz, Laurel B. Darragh, et al.. (2021). FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC. Clinical Cancer Research. 27(22). 6235–6249. 22 indexed citations

Barry, Kevin C., et al.. (2021). The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy. Frontiers in Immunology. 11. 621254–621254. 51 indexed citations

Minot, Samuel S., et al.. (2021). geneshot: gene-level metagenomics identifies genome islands associated with immunotherapy response. Genome biology. 22(1). 135–135. 14 indexed citations

Bald, Tobias, Matthew F. Krummel, Mark J. Smyth, & Kevin C. Barry. (2020). The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies. Nature Immunology. 21(8). 835–847. 364 indexed citations breakdown →

Brown, Chad, et al.. (2019). Priorities for Services in Young Patients With Atherosclerotic Cardiovascular Disease and Their Family Members: An Exploratory Mixed-Methods Study. CJC Open. 1(3). 107–114. 2 indexed citations

Binnewies, Mikhail, Adriana M. Mujal, Joshua L. Pollack, et al.. (2019). Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 177(3). 556–571.e16. 443 indexed citations breakdown →

Barry, Kevin C. & Matthew F. Krummel. (2019). Abstract PR04: A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments. Cancer Immunology Research. 7(2_Supplement). PR04–PR04. 3 indexed citations

10.

Qiu, Jiazhang, Christopher J. Nicolai, Jessica L. Counihan, et al.. (2017). Positive and Negative Regulation of the Master Metabolic Regulator mTORC1 by Two Families of Legionella pneumophila Effectors. Cell Reports. 21(8). 2031–2038. 49 indexed citations

11.

Barry, Kevin C., Nicholas T. Ingolia, & Russell E. Vance. (2017). Global analysis of gene expression reveals mRNA superinduction is required for the inducible immune response to a bacterial pathogen. eLife. 6. 35 indexed citations

12.

Ye, Jordan, Miranda L. Broz, Kevin C. Barry, et al.. (2016). Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. Journal of Clinical Investigation. 126(12). 4417–4429. 62 indexed citations

13.

Fu, Zhu, et al.. (2014). Pseudomonas aeruginosa Quorum-Sensing Molecule Homoserine Lactone Modulates Inflammatory Signaling through PERK and eI-F2α. The Journal of Immunology. 193(3). 1459–1467. 25 indexed citations

14.

Barry, Kevin C., et al.. (2013). IL-1α Signaling Initiates the Inflammatory Response to Virulent Legionella pneumophila In Vivo. The Journal of Immunology. 190(12). 6329–6339. 106 indexed citations

15.

Barry, Kevin C., et al.. (2011). TheDrosophilaSTUbL protein Degringolade limits HES functions during embryogenesis. Development. 138(9). 1759–1769. 24 indexed citations

16.

Abed, Mona, Kevin C. Barry, T. Phippen, et al.. (2011). Degringolade, a SUMO‐targeted ubiquitin ligase, inhibits Hairy/Groucho‐mediated repression. The EMBO Journal. 30(7). 1289–1301. 56 indexed citations

17.

Fontana, Mary F., Simran Banga, Kevin C. Barry, et al.. (2011). Secreted Bacterial Effectors That Inhibit Host Protein Synthesis Are Critical for Induction of the Innate Immune Response to Virulent Legionella pneumophila. PLoS Pathogens. 7(2). e1001289–e1001289. 173 indexed citations

18.

Liu, Raymond, et al.. (2009). Wash functions downstream of Rho and links linear and branched actin nucleation factors. Development. 136(16). 2849–2860. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact